Research & Development
Formulation Regulatory
Home>Research & Development> Formulation Regulatory

Formulation Regulatory

Our formulation development group has a broad experience in developing different dosage forms for clinical studies and for commercial manufacturing. We develop everything from simple formulations for early studies to formulations suited for large scale manufacturing. The staff has a high educational level and is skilled in design of experiments which enable a scientific approach to the development leading to reduced timelines and costs.

We develop a number of different dosage forms such as:

  • Liquids; oral and topical, suspensions and emulsions
  • Semi-solids such as gels, controlled release gels, ointments, creams and suppositories
  • Pharmaceutical patches
  • Powders and granules
  • Capsules, coated capsules, capsules filled with un-coated or coated particles
  • Tablets, immediate-release tablets, coated tablets, enteric-coated tablets, sustained release tablets, tablets with active substance(s) in different layers
  • Parenterals and other sterile products
  • Protein formulations

Our formulation development services include:

  • Pre-formulation studies
  • Drug substance and excipient compatibility studies
  • Early screening for structural and chemical stability
  • Development of formulations for pre-clinical studies and clinical studies phase I to III
  • Manufacturing of batches for stability studies
  • Development of formulations for application of marketing authorisation
  • Scale-up and pilot scale manufacturing
  • Technology transfer and process validation
  • Compilation of CMC regulatory documents

Swiss offers a comprehensive package of analytical services to support your product development and marketed product activities.

From early candidate analysis to ANDA submission,Swiss can help accelerate your efforts by providing immediate resourcing and technical expertise to support your product.